
Sign up to save your podcasts
Or


As war rages and Donald Trump looms, a recent election featured little mention of the ailing $164 bln drugmaker, once so successful it distorted economic figures. In this week’s Viewsroom, Breakingviews columnists discuss the future of weight loss pills, and Novo’s place in it.
Novo Nordisk’s falling knife is still gathering speed
Obesity pills are shaky Hail Mary for Novo Nordisk
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Reuters4.2
4646 ratings
As war rages and Donald Trump looms, a recent election featured little mention of the ailing $164 bln drugmaker, once so successful it distorted economic figures. In this week’s Viewsroom, Breakingviews columnists discuss the future of weight loss pills, and Novo’s place in it.
Novo Nordisk’s falling knife is still gathering speed
Obesity pills are shaky Hail Mary for Novo Nordisk
Learn more about your ad choices. Visit megaphone.fm/adchoices

7,913 Listeners

4,225 Listeners

523 Listeners

4,420 Listeners

296 Listeners

427 Listeners

33 Listeners

686 Listeners

684 Listeners

1,089 Listeners

64 Listeners

302 Listeners

150 Listeners

146 Listeners

29 Listeners